Personalized mRNA Therapeutic Cancer Vaccines: A New Chapter in Oncology
After mRNA vaccines achieved remarkable success during the COVID-19 pandemic a few years ago, cancer vaccines have continued to attract attention as a promising approach to cancer immunotherapy. Yesterday, Merck and Moderna announced positive Phase 3 results for their personalized mRNA cancer vaccine approach in patients with high-risk melanoma. This is an important milestone for […]